[Post-radiation choroidal melanoma pathomorphosis assessment in clinical practice]

I E Panova1,2,3, E M Svistunova1, E V Samkovich1

  • 1S. Fyodorov Eye Microsurgery Federal State Institution, the St. Petersburg Branch, St. Petersburg, Russia.

Arkhiv Patologii
|June 18, 2025
PubMed
Summary

Secondary enucleation after choroidal melanoma (CM) treatments revealed persistent viable tumor cells and mitotic activity. This indicates a high risk of continued tumor growth and metastasis, even after organ-preserving therapies.